AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand · Delayed Price · Currency is NZD 3.980
+0.050 (1.27%)
Jun 2, 2026, 11:03 AM NZST
AFT Pharmaceuticals Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 14.73 | 11.96 | 15.61 | 10.65 | 19.85 |
Depreciation & Amortization | 1.3 | 1.2 | 1.2 | 0.85 | 0.91 |
Other Amortization | 2.4 | 1.47 | 0.81 | 0.88 | 0.13 |
Loss (Gain) From Sale of Assets | - | - | 0.57 | 0.53 | - |
Stock-Based Compensation | 0.05 | 0.04 | 0.14 | - | 0.01 |
Other Operating Activities | 6.16 | 4.97 | 9.03 | 5.67 | 0.72 |
Change in Accounts Receivable | -15.67 | -4.34 | 2.5 | -10.72 | -4.96 |
Change in Inventory | -25.59 | 0.58 | -6.66 | -8.9 | 0.15 |
Change in Accounts Payable | 7.09 | -2.7 | 5.67 | 12.67 | -2.66 |
Operating Cash Flow | -9.54 | 13.18 | 28.86 | 11.63 | 14.15 |
Operating Cash Flow Growth | - | -54.35% | 148.18% | -17.83% | 1786.93% |
Capital Expenditures | -0.12 | -0.28 | -0.12 | -0.2 | -0.33 |
Sale (Purchase) of Intangibles | -9.64 | -6.67 | -9.41 | -8.98 | -5.26 |
Investing Cash Flow | -9.76 | -6.95 | -9.53 | -9.18 | -5.59 |
Short-Term Debt Issued | 0.61 | 1.08 | - | - | - |
Long-Term Debt Issued | 92.4 | 16.6 | - | - | 5 |
Total Debt Issued | 93.01 | 17.68 | - | - | 5 |
Long-Term Debt Repaid | -79.85 | -20.02 | -5.86 | -4.59 | -5.38 |
Net Debt Issued (Repaid) | 13.16 | -2.34 | -5.86 | -4.59 | -0.38 |
Issuance of Common Stock | - | - | - | 0.48 | 0.3 |
Common Dividends Paid | -1.89 | -1.68 | -1.15 | - | - |
Dividends Paid | -1.89 | -1.68 | -1.15 | - | - |
Other Financing Activities | -2.48 | -2.8 | -3.62 | -2.86 | -2.19 |
Financing Cash Flow | 8.79 | -6.81 | -10.63 | -6.98 | -2.28 |
Foreign Exchange Rate Adjustments | -0.25 | -0.34 | 0.05 | -0.12 | 0.1 |
Net Cash Flow | -10.75 | -0.93 | 8.75 | -4.65 | 6.39 |
Free Cash Flow | -9.66 | 12.9 | 28.75 | 11.43 | 13.82 |
Free Cash Flow Growth | - | -55.14% | 151.44% | -17.30% | 2003.96% |
Free Cash Flow Margin | -3.79% | 6.20% | 14.71% | 7.30% | 10.61% |
Free Cash Flow Per Share | -0.09 | 0.12 | 0.27 | 0.11 | 0.13 |
Cash Interest Paid | 2.49 | 2.82 | 3.69 | 2.87 | 2.2 |
Cash Income Tax Paid | 5.12 | 2.21 | 1.22 | 1.34 | 0.22 |
Levered Free Cash Flow | -20.96 | -2.35 | 10.16 | -4.97 | -0.03 |
Unlevered Free Cash Flow | -19.41 | -0.58 | 12.46 | -3.17 | 1.49 |
Change in Working Capital | -34.18 | -6.46 | 1.5 | -6.95 | -7.47 |